Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 314641 - 314660 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Lithuania | (L04AF02) baricitinib (adm: O) | Olumiant 4 mg plėvele dengtos tabletės N28 (Eli Lilly Nederland B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | EliLillyNederlandB.V.,Nyderlandai |
| Lithuania | (L04AF02) baricitinib (adm: O) | Olumiant 4 mg plėvele dengtos tabletės N98 (Eli Lilly Nederland B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | EliLillyNederlandB.V.,Nyderlandai |
| Lithuania | (L04AF03) upadacitinib (adm: O) | RINVOQ 15 mg pailginto atpalaidavimo tabletės N28 (AbbVie Deutschland GmbH & Co. KG , Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbVieDeutschlandGmbH&Co.KG,Vokietija |
| Lithuania | (L04AF03) upadacitinib (adm: O) | RINVOQ 30 mg pailginto atpalaidavimo tabletės N28 (AbbVie Deutschland GmbH & Co. KG , Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbVieDeutschlandGmbH&Co.KG,Vokietija |
| Lithuania | (L04AF03) upadacitinib (adm: O) | RINVOQ 30 mg pailginto atpalaidavimo tabletės N28 (AbbVie Deutschland GmbH & Co. KG , Vokietija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbVieDeutschlandGmbH&Co.KG,Vokietija |
| Lithuania | (L04AF03) upadacitinib (adm: O) | RINVOQ 45 mg pailginto atpalaidavimo tabletės N28 (AbbVie Deutschland GmbH & Co. KG , Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | AbbVieDeutschlandGmbH&Co.KG,Vokietija |
| Lithuania | (L04AG03) natalizumab (adm: P) | Tysabri 300 mg koncentratas infuziniam tirpalui 15 ml N1 (Biogen Netherlands B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenNetherlandsB.V.,Nyderlandai |
| Lithuania | (L04AG03) natalizumab (adm: P) | Tysabri 300 mg koncentratas infuziniam tirpalui 15 ml N1 (Biogen Netherlands B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenNetherlandsB.V.,Nyderlandai |
| Lithuania | (L04AG03) natalizumab (adm: P) | Tysabri 150 mg injekcinis tirpalas užpildytame švirkšte 1 ml N2 (Biogen Netherlands B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenNetherlandsB.V.,Nyderlandai |
| Lithuania | (L04AG03) natalizumab (adm: P) | Tysabri 150 mg injekcinis tirpalas užpildytame švirkšte 1 ml N2 (Biogen Netherlands B.V., Nyderlandai) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenNetherlandsB.V.,Nyderlandai |
| Lithuania | (L04AG04) belimumab (adm: P) | Benlysta 200 mg injekcinis tirpalas užpildytame švirkštiklyje 1 ml N4 (GlaxoSmithKline (Ireland) Limited , Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline[Ireland]Limited,Airija |
| Lithuania | (L04AG04) belimumab (adm: P) | Benlysta 200 mg injekcinis tirpalas užpildytame švirkštiklyje 1 ml N4 (GlaxoSmithKline (Ireland) Limited , Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline[Ireland]Limited,Airija |
| Lithuania | (L04AG04) belimumab (adm: P) | Benlysta 120 mg milteliai infuzinio tirpalo koncentratui N1 (GlaxoSmithKline (Ireland) Limited , Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline[Ireland]Limited,Airija |
| Lithuania | (L04AG04) belimumab (adm: P) | Benlysta 120 mg milteliai infuzinio tirpalo koncentratui N1 (GlaxoSmithKline (Ireland) Limited , Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline[Ireland]Limited,Airija |
| Lithuania | (L04AG04) belimumab (adm: P) | Benlysta 400 mg milteliai infuzinio tirpalo koncentratui N1 (GlaxoSmithKline (Ireland) Limited , Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline[Ireland]Limited,Airija |
| Lithuania | (L04AG04) belimumab (adm: P) | Benlysta 400 mg milteliai infuzinio tirpalo koncentratui N1 (GlaxoSmithKline (Ireland) Limited , Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKline[Ireland]Limited,Airija |
| Lithuania | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg injekcinis tirpalas užpildytame švirkštiklyje N2 (2x1) (Takeda Pharma A/S, Danija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaA/S,Danija |
| Lithuania | (L04AG05) vedolizumab (adm: P) | Entyvio 300 mg milteliai infuzinio tirpalo koncentratui N1 (Takeda Pharma A/S, Danija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaA/S,Danija |
| Lithuania | (L04AG06) alemtuzumab (adm: P) | Lemtrada 12 mg koncentratas infuziniam tirpalui 1,2 ml N1 (Sanofi Belgium, Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | SanofiBelgium,Belgija |
| Lithuania | (L04AG08) ocrelizumab (adm: P) | Ocrevus 300 mg koncentratas infuziniam tirpalui 10 ml N1 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | RocheRegistrationGmbH,Vokietija |
Pages
